Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Mass Balance of SK-1404 in Healthy Males
NCT02878096Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jul 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lazuvapagon in nocturia, sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoints: Absolute bioavailability (F), Mass balance recovery of total radioactivity and 1 more. Started Jul 2016; status: completed.
02
Drugs
lazuvapagon
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT02878096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878096.